Table 2.
Outcome cfPWV: Univariable Analysis.
| Patient Characteristics | Estimate ± SE | P-value |
|---|---|---|
| Age (years) | 0.10 ± 0.02 | < 0.0001 |
| Male | −0.16 ± 0.17 | 0.35 |
| Black | 0.47 ± 0.21 | 0.03 |
| Height (cm) | 0.02 ± 0.00 | < 0.001 |
| BMI (kg/m2) | 0.05 ± 0.01 | 0.001 |
| Waist circumference (cm) | 0.01 ± 0.01 | 0.03 |
| Glomerular diagnosis | 0.38 ± 0.17 | 0.03 |
| GFR (per 10 ml/min/1.73m2) | −0.00 ± 0.03 | 0.96 |
| Urine protein-creatinine ratio (mg/mg) | ||
| < 0.5 | Reference | Reference |
| ≥ 0.5 | 0.38 ± 0.19 | 0.05 |
| Systolic blood pressure percentile | 0.01 ± 0.00 | 0.02 |
| Diastolic blood pressure percentile | 0.00 ± 0.00 | 0.14 |
| Mean arterial pressure (mmHg) | 0.03 ± 0.01 | 0.001 |
| Heart rate (bpm) | −0.01 ± 0.01 | 0.12 |
| Number of anti-HTN medications | ||
| 0 | Reference | Reference |
| 1 | 0.34 ± 0.21 | 0.11 |
| ≥ 2 | 0.46 ± 0.28 | 0.10 |
| Triglycerides (per 10 mg/dL) | 0.01 ± 0.02 | 0.40 |
| LDL cholesterol (per 10 mg/dL) | 0.03 ± 0.02 | 0.14 |
| HDL cholesterol (per 10 mg/dL) | 0.05 ± 0.05 | 0.26 |
| Calcium x phosphate (mg2/dL2) | −0.01 ± 0.01 | 0.60 |
| Uric acid (mg/dL) | 0.12 ± 0.05 | 0.03 |
| Serum glucose (per 10 mg/dL) | 0.05 ± 0.09 | 0.57 |
| Length of time with CKD | 0.01 ± 0.01 | 0.71 |
SE, standard error; BMI, body mass index; LDL, low density lipoproteins; HDL, high density lipoproteins; cfPWV, carotid-femoral pulse wave velocity.